CreditReports.dk
HomeScreen companies

SCANPHARM A/S Financials, key figures and credit report

CVR number: 16279099 Established 1992 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Topstykket 12, 3460 Birkerød tel: 45826046
Gross profit 29 716.7 kDKK FY 2025 +10.5% vs 2024
EBIT 1 721.4 kDKK FY 2025 +2.5% vs 2024
Net debt 21 248.1 kDKK FY 2025 +6.2% vs 2024
Quick ratio 0.5 FY 2025 -0 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit11 259.4317 399.1422 519.4326 903.8029 716.68
Employee benefit expenses-18 905.94-21 127.92-24 334.74-23 961.64-24 519.98
Other operating expenses- 334.46- 334.46-1 724.53
Total depreciation-1 737.32-1 810.61-1 717.31-1 262.68-1 750.78
EBIT-9 718.29-5 204.94-3 532.621 679.481 721.39
Other financial income38.46108.27
Other financial expenses-1 305.70-1 407.55- 986.17-1 135.25- 866.94
Pre-tax profit-10 784.66-6 105.89-4 424.69582.68962.72
Income taxes-85.92151.43
Net earnings-10 870.59-5 954.45-4 424.69582.68962.72

Assets (kDKK)

2021
2022
2023
2024
2025
Goodwill283.78137.5841.08
Intangible assets total283.78137.5841.08
Buildings13 673.9713 081.6113 724.5616 364.7414 663.46
Machinery and equipment359.40313.60275.59240.31147.70
Tangible assets total14 033.3813 395.2114 000.1516 605.0514 811.16
Investments total
Long term receivables total
Raw materials and consumables2 725.765 840.968 317.134 572.318 199.15
Finished products/goods2 502.80717.12880.75822.121 231.29
Advance payments551.51
Inventories total5 228.566 558.089 749.405 394.449 430.44
Current other receivables8 636.888 688.146 930.8912 188.8414 085.85
Current deferred tax assets728.57880.00880.00880.00880.00
Short term receivables total9 365.459 568.147 810.8913 068.8414 965.85
Balance sheet total (assets)28 911.1729 659.0231 601.5235 068.3239 207.45

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital3 000.003 000.003 000.003 000.003 000.00
Asset revaluation reserve1 424.591 360.941 297.301 233.65
Retained earnings7 945.993 093.511 627.39-2 733.65- 917.32
Profit of the financial year-10 870.59-5 954.45-4 424.69582.68962.72
Shareholders equity total1 500.001 500.001 500.002 082.683 045.41
Non-current leasing loans2 408.891 478.592 264.211 735.121 786.15
Non-current other liabilities1 537.001 428.651 361.091 403.281 409.41
Non-current liabilities total3 945.892 907.243 625.293 138.403 195.56
Current loans from credit institutions12 360.798 094.009 976.219 006.2710 266.71
Advances received348.621 119.101 432.53157.36
Current trade creditors4 738.443 763.814 253.345 904.937 334.16
Current owed to group member4 182.559 154.237 967.0410 993.9110 981.41
Other non-interest bearing current liabilities1 834.893 120.634 279.642 509.604 226.84
Current liabilities total23 465.2825 251.7826 476.2229 847.2432 966.49
Balance sheet total (liabilities)28 911.1729 659.0231 601.5235 068.3239 207.45
Page generated